Categories: Market Research

Global Point Of Care Molecular Diagnostics Market Size and Forecast 2023-2032|Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation,

The Point Of Care Molecular Diagnostics Global Market Report 2023 by The Business Research Company, provides point of care molecular diagnostics market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Point Of Care Molecular Diagnostics Market:

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

According to The Business Research Company’s Point Of Care Molecular Diagnostics Global Market Report 2023, the market size grew from $2.8 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 12.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the point-of-care molecular diagnostics market is expected to grow to $4.98 billion in 2027 at a CAGR of 12.2%.

The rapid growth in the increasing occurrence of infectious and respiratory diseases is expected to significantly contribute to the growth of the point-of-care molecular diagnostics market. Respiratory infections, such as viruses or bacteria, are caused by microorganisms that influence the respiratory system. These microbes can be transferred through coughing, sneezing, or direct touch. The severity of the respiratory medications includes a variety of inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostic to cure the patient.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=7046&type=smp

The point of care molecular diagnostics market is segmented:

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Technological innovation is a key trend gaining popularity in the point-of-care molecular diagnostics market. Major companies operating in the point-of-care molecular diagnostics market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation point-of-care molecular diagnostics technologies solutions and related services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and others to implement on POC devices with features of accelerating analysis times and lowering costs. For instance, in March 2020, Abbott Laboratories, a US-based medical device company, launched the molecular point-of-care test available for detecting new COVID-19 (COVID-19). According to the company, the device shows positive results in five minutes and negative in 13 minutes. This test will run on the ID NOW™ platform with isothermal nucleic acid amplification technology that generates molecular results in minutes.

The point of care molecular diagnostics market report table of contents includes:

1. Executive Summary

2. Point-Of-Care Molecular Diagnostics Market Characteristics

3. Point-Of-Care Molecular Diagnostics Market Trends And Strategies

4. Point-Of-Care Molecular Diagnostics – Macro Economic Scenario

5. Point-Of-Care Molecular Diagnostics Market Size And Growth

26. Africa Point-Of-Care Molecular Diagnostics Market

27. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market

29. Point-Of-Care Molecular Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

Top Major Players: